Emergent BioSolutions Inc. (EBS)
NYSE·Healthcare·Biotechnology
$8.20
+5.86%
Mkt Cap $427.73M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+46.3%
Consensus $12.00 vs current $8.20
NYSE·Healthcare·Biotechnology
$8.20
+5.86%
Mkt Cap $427.73M
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$12.00
Range $12.00 – $12.00
+46.3%
Consensus $12.00 vs current $8.20